Baylor Genetics Epilepsy Panel, STAT Epilepsy Panel

Baylor Genetics has launched the Epilepsy Panel and STAT Epilepsy Panel. The next-generation sequencing-based Epilepsy Panel analyzes 397 genes that are associated with epilepsy, such as Angelman syndrome, Rett syndrome, SCN1A-related epilepsies, CDKL5 deficiency disorder, Charcot-Marie-Tooth disease, and developmental and epileptic encephalopathies. The STAT Epilepsy Panel is intended for use with patients with new onset of disease or a change in seizure frequency or character, Baylor Genetics said, adding that the turnaround time for the test is 10 days.